Boothbay Fund Management’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

Boothbay Fund Management’s Portfolio NRXPW Stock Details NRXPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-34,063	Closed	-$365K	–	1366
2020 Q3	$365K	Sell	34,063 -100	-0.3%	-$27	0.02%	760
2020 Q2	$359K	Hold	34,163	–	–	0.02%	655
2020 Q1	$368K	Hold	34,163	–	–	0.03%	518
2019 Q4	$362K	Hold	34,163	–	–	0.03%	569
2019 Q3	$361K	Hold	34,163	–	–	0.03%	528
2019 Q2	$360K	Hold	34,163	–	–	0.03%	500
2019 Q1	$353K	Hold	34,163	–	–	0.03%	468
2018 Q4	$13K	Hold	34,163	–	–	﹤0.01%	623
2018 Q3	$342K	Hold	34,163	–	–	0.03%	467
2018 Q2	$339K	Hold	34,163	–	–	0.03%	445
2018 Q1	$334K	Hold	34,163	–	–	0.04%	435
2017 Q4	$331K	Buy	+34,163	New	+$13K	0.05%	398

Other funds holding NRXPW

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Boothbay Fund Management's NRXPW Position: Q4 2020 in Review

Boothbay Fund Management sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q4 2020, closing a stake of 34,063 shares — an estimated $365K sold.

Boothbay Fund Management first reported a position in NRXPW in Q4 2017 and held it in 12 quarters. The position peaked at $368K in Q1 2020. 2 funds tracked by Wall St. Rank hold NRXPW as of Q4 2020.

Boothbay Fund Management reported no remaining NRX Pharmaceuticals Warrant position as of Q4 2020 after selling out during the quarter.
Boothbay Fund Management sold 34,063 NRX Pharmaceuticals Warrant shares in Q4 2020, an estimated $365K.
Boothbay Fund Management first reported a position in NRX Pharmaceuticals Warrant in Q4 2017 and held it in 12 quarters.
Boothbay Fund Management's NRX Pharmaceuticals Warrant position peaked at $368K in Q1 2020.
2 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q4 2020.

Based on Boothbay Fund Management's 13F filing for Q4 2020, filed 12 Feb 2021.